Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial miss

Kolon TissueGene shrinks workforce after pivotal osteoarthritis trial miss

August 18, 2026Posted inBiotechnology

Following a phase 3 knee osteoarthritis failure that its CEO acknowledged caused “great disappointment and concern,” Kolon TissueGene is laying off 37 employees at its Maryland headquarters.

Post navigation

Previous Post
Exercise-Boosting Molecule May Help Improve Muscle Health in Type 2 Diabetes
Next Post
TUM develops single-photon sources to advance quantum communication tum-develops-single-photon-sources-to-advance-quantum-communication

Recent Posts

  • Coal power expansion linked to sharply higher urban air-pollution deaths in India
  • TAC-linked multimetal MOF enables 13-day cycling in rechargeable zinc–air battery
  • Cuticular DNA identifies hosts of adult parasitoid wasps
  • MRI links trigeminal neuralgia to cerebellar thickness and postoperative changes
  • Elevated ELABELA levels distinguish neonatal risk groups from controls

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top